In order to provide the best user experience, we had to abandon support for Internet Explorer versions prior to IE9. Upgrade your browser.

Article 3 (Feb 2019): Tech Advances Spur Heart Diagnosis and Care

February 21, 2019
The future of cardiovascular care will be steered by artificial intelligence and wearable mobile devices, according to articles published in The Journal of the American College of Cardiology.

Every stage of patient care will be enhanced by artificial intelligence, according to Joel Dudley, director of the Next Generation Healthcare Institute at Mount Sinai.  AI will steer research, diagnosis and selection of therapy, he said.  The next step will bring technologies to a clinical setting.
 
In areas of patient health improvement and health-care delivery, digital health applies information to produce solutions. These technologies have the potential to streamline research while saving money; however, delays in their implementation are often the result of concerns regarding data quality, patient safety, and privacy.
 
Meanwhile, wearable mobile devices will continue to help manage heart problems.  It takes a personal commitment to a heart-healthy lifestyle of diet and exercise, medication, and self-monitoring to manage heart health.  It is here that ever-increasing use of mobile devices and wearables have made 24-hour health monitoring a reality for so many--especially those with atrial fibrillation, a heart rhythm disorder.
 
The authors targeted AFib, in particular, which is hard to detect and difficult to manage.  Office visits and short-term monitoring only provide limited information on the presence of the disease, but mobile health -- called mHealth -- will offer a more complete picture that can help prevent strokes, control symptoms, and reduce hospitalizations.
 
According to Dr. Michael McConnell, a Stanford clinical professor, the medical community has just begun to embrace the reality that health takes place outside the hospital and clinic.  New technologies, he said, will transform cardiovascular disease prevention and management.
International: 856-762-0172
Domestic: 800-822-9190

Repco Quick Contact

If you do not see what you need, please let us know what it is and we''ll do our best to help you.

First name required.
Last name required.
Company required.
Valid email required.
Phone number required.
Send your inquiry now and we will respond promptly.
Interest is in general information for pagename=articles/Article_3__Feb_2019___Tech_Advances_Spur_Heart_Diagnosis_and_Care
Comment required.

Site Search

OEM, Product, Repco ID #s or Terms